What CGM data tells your endocrinologist: beyond A1C
Reviewed for clinical accuracy by the EndoInnova care team, led by Dr. Sheila S. Mercado Méndez, board-certified endocrinologist in Diabetes and Metabolism — Carrizales, Hatillo, Puerto Rico.
A continuous glucose monitor (CGM) is a small wearable sensor that measures glucose in the fluid just beneath the skin and sends a reading to a phone or receiver every few minutes, day and night. It is most often used by people with Type 1 diabetes, people with Type 2 diabetes who use insulin, and anyone whose glucose swings are hard to explain with fingersticks alone.
If you have been told your A1C looks “fine” but you still feel shaky in the afternoons — or if you are doing everything right and your numbers still move unpredictably — a CGM may be the missing piece. This guide from your endocrinologist in Puerto Rico explains what a CGM is, how it differs from a traditional glucometer, who benefits most, and what to discuss with your specialist before starting one. It is part of our ongoing diabetes education Puerto Rico series, written for patients across Hatillo and the north coast.
What is a continuous glucose monitor?
A CGM is a wearable glucose-tracking system with three working parts: a hair-thin sensor filament inserted just under the skin (usually on the upper arm or abdomen), a small transmitter that sits on top of it, and an app or handheld receiver that displays the readings. Rather than capturing one number at one moment, continuous glucose monitoring estimates your glucose automatically throughout the day and night, so you can see the direction it is heading and how far it has traveled since breakfast, since your walk, or since you fell asleep.
Most sensors are worn for 10 to 15 days before being replaced. Many current systems are factory-calibrated, meaning no daily fingerstick calibration is required, though a meter is still recommended for confirming readings in specific situations.
Historically every CGM required a prescription. That changed when the U.S. Food and Drug Administration cleared the first over-the-counter CGM for adults who do not use insulin, and later extended an OTC clearance to children ages two and older who do not use insulin. Wider availability is genuinely useful — but it also means more people are now wearing sensors without clinical guidance on how to read them.
How a CGM works — and why the number may differ from your meter
A CGM does not measure blood directly. It measures glucose in interstitial fluid, the fluid surrounding the cells under your skin. Glucose reaches that fluid slightly after it reaches your bloodstream, which produces a lag of roughly five to fifteen minutes.
That lag matters in practice:
- When glucose is stable, sensor and meter readings usually track closely.
- When glucose is rising or falling quickly — after a meal, during exercise, or while correcting a low — the sensor can read noticeably higher or lower than a fingerstick taken at the same second.
- If your symptoms do not match what the sensor shows, confirm with a fingerstick before acting.
This is also why trend arrows matter as much as the number itself. A reading of 110 mg/dL with a steady arrow and a reading of 110 mg/dL with a steep downward arrow call for two completely different responses. Learning to read arrows correctly is one of the first things we work on with new CGM users.
CGM vs. glucometer: the difference explained
A glucometer is not obsolete. It remains accurate, inexpensive, and essential as a backup. The two tools answer different questions — a meter answers “what is my glucose right now?” while a CGM answers “what has my glucose been doing, and where is it going?”
Feature | Glucometer (fingerstick) | Continuous glucose monitor |
What it measures | Glucose in a drop of capillary blood | Glucose in interstitial fluid under the skin |
Readings per day | Only when you test — typically 1 to 6 | Automatic, roughly every 1 to 15 minutes |
Overnight data | Only if you wake up to test | Captured continuously while you sleep |
Alerts | None | Customizable high, low, and rate-of-change alerts on most systems |
Shows trends | No — isolated snapshots | Yes — direction, speed, and daily patterns |
Reports for your doctor | Manual logbook or meter download | Ambulatory Glucose Profile and time-in-range summaries |
Fingersticks needed | Every reading | Few or none, depending on the system |
Best role | Confirming a reading; backup during sensor errors | Understanding patterns and guiding treatment adjustments |
Who needs a continuous glucose monitor?
There is no single answer that fits everyone. The honest version is that CGM is now considered standard for some groups, strongly worth discussing for others, and optional for the rest. Below is how we frame the conversation at our clinic.
1. Adults and children with Type 1 diabetes
For most people living with Type 1 diabetes, CGM is no longer considered optional technology. The American Diabetes Association’s Standards of Care in Diabetes — Diabetes Technology describes continuous glucose monitoring as standard of care for most people with Type 1 diabetes, and recommends starting it early after diagnosis. If you are looking for a Type 1 diabetes doctor PR patients can see locally, ask directly whether sensor data is reviewed at every visit — not just A1C.
2. People with Type 2 diabetes who use insulin
If you take basal insulin, mealtime insulin, or both, a CGM gives you and your specialist visibility into the two things fingersticks miss most often: overnight lows and post-meal spikes. That visibility is frequently what allows insulin doses to be adjusted with more confidence and less trial and error.
3. People with Type 2 diabetes not using insulin
Guideline eligibility has broadened here, and CGM may be appropriate for people on non-insulin therapies when the data helps guide glucose management. For many patients, wearing a sensor for a defined period is essentially a learning tool — it shows what rice and habichuelas, a mid-afternoon coffee, or an evening walk actually do to their glucose. Discuss with your specialist whether short-term or ongoing wear fits your Type 2 diabetes treatment Puerto Rico plan.
4. Anyone with frequent, severe, or unrecognized hypoglycemia
Predictive low alerts are one of the strongest arguments for CGM. If you have hypoglycemia unawareness — meaning you no longer feel the early warning signs of a low — a sensor that can alert you before you drop is a meaningful safety layer, particularly overnight and while driving.
5. Pregnancy and gestational diabetes
Glucose targets in pregnancy are tighter and change quickly across trimesters. CGM use in pregnancy is an active area of research and should always be individualized with your endocrinologist and obstetric team together.
6. Prediabetes, insulin resistance, and metabolic health
Interest here has grown quickly, and over-the-counter sensors have made access easy. A word of caution, though: research has found that CGM metrics in people with prediabetes and normal glucose levels do not necessarily align with A1C, which means a sensor reading interpreted without clinical context can create unnecessary alarm — or false reassurance. If you wear an OTC sensor, bring the report to a specialist rather than drawing conclusions alone.
Who may not need one
If you have Type 2 diabetes managed with lifestyle alone, stable results, no hypoglycemia, and no unexplained variability, a CGM may add cost and data without changing your plan. Some people also find constant numbers stressful. Both are legitimate reasons to decide against one, and that decision can always be revisited.
What CGM data tells your endocrinologist: beyond A1C
A1C remains valuable, but it is an average — and averages hide the extremes. Two people can share an identical A1C while one runs steady and the other swings between 50 and 300 mg/dL all week. CGM reporting closes that gap using a standardized set of metrics:
- Time in Range (TIR): the percentage of the day spent between 70 and 180 mg/dL.
- Time Below Range (TBR): time spent low — often the first metric reviewed, because hypoglycemia carries the most immediate risk.
- Time Above Range (TAR): time spent high, and when in the day it clusters.
- Glucose variability: how sharply levels rise and fall rather than how high they reach.
- Ambulatory Glucose Profile (AGP): a one-page visual summary that overlays your typical day.
The international consensus on time in range set widely used reference targets, including greater than 70% time in range for many non-pregnant adults with Type 1 or Type 2 diabetes, with lower targets and stricter hypoglycemia limits for older adults and those at higher risk. These are reference points, not universal goals — your individual targets should always be set with your physician.
Benefits and limitations, honestly stated
What patients tend to gain
- Visibility into overnight glucose without setting an alarm at 3 a.m.
- Clear feedback on how specific meals, medications, stress, and exercise affect them personally.
- Fewer routine fingersticks with most current systems.
- Alerts that can flag a low before symptoms appear.
- Compatibility with automated insulin delivery systems, in which a CGM communicates with an insulin pump — an approach the NIH describes in its overview of the artificial pancreas.
What to plan for
- Cost and insurance coverage vary by plan and by diagnosis; verify your benefits before ordering.
- Adhesive performance is a real consideration in Puerto Rico’s heat and humidity. Overpatches and proper site prep make a noticeable difference.
- Skin irritation at the sensor site occurs for some users and is worth reporting early.
- Sensor lag means the number is an estimate, not a laboratory value.
- Some people experience data fatigue or anxiety from constant alerts; alert thresholds can and should be adjusted.
Starting a CGM in Puerto Rico: what the process looks like
Puerto Rico carries one of the highest reported burdens of diagnosed diabetes among U.S. states and territories, a pattern documented consistently in population health research on Puerto Rican adults. Access to specialized, endocrinology-led follow-up matters here — and that is exactly the gap a well-run diabetes management clinic is meant to close.
- Clinical evaluation. Your diabetes type, treatment plan, hypoglycemia history, and goals are reviewed by a diabetes specialist Puerto Rico patients can see for ongoing care — not a one-time consultation.
- Device selection. Systems differ in wear time, alert design, phone compatibility, and coverage. The right one is the one you will realistically keep wearing.
- Prescription and insurance verification. Documentation requirements vary; our team confirms current criteria with your plan before you order.
- Insertion and training. You learn placement, adhesive care in humid conditions, alert setup, and — most importantly — what to do with each trend arrow.
- Data review and adjustment. At follow-up, your AGP and time-in-range data are reviewed together and your plan is adjusted based on what the sensor actually shows.
At EndoInnova, that process is led by Dr. Sheila S. Mercado Méndez, a board-certified endocrinologist Puerto Rico patients travel to Hatillo to see for specialized diabetes and metabolic care. Working with a board-certified diabetes doctor means your sensor data is interpreted alongside your labs, medications, thyroid function, and body composition — not in isolation. Learn more about our endocrinologist for diabetes in Puerto Rico services, or read our Spanish-language guide to manejo de la diabetes for the same information in español.
Resumen en español: monitor continuo de glucosa en Puerto Rico
Un monitor continuo de glucosa (CGM, por sus siglas en inglés) es un sensor pequeño que se coloca debajo de la piel y mide el nivel de azúcar en la sangre de forma automática, día y noche. El monitoreo continuo de glucosa muestra hacia dónde va su azúcar, no solo dónde está en ese momento.
¿Quién necesita un monitor continuo de glucosa?
Generalmente se recomienda evaluar el uso de un sensor de glucosa Puerto Rico en estos casos:
- CGM para diabetes tipo 1 — la mayoría de los pacientes se benefician del uso continuo.
- CGM para diabetes tipo 2 en pacientes que usan insulina.
- Pacientes con bajones de azúcar frecuentes o que ya no sienten los síntomas de hipoglucemia.
- Pacientes con azúcar en la sangre que sube y baja sin explicación clara.
Entre los beneficios del monitor continuo de glucosa están las alertas de bajones, la información de lo que pasa mientras usted duerme, y los informes que su endocrinóloga puede revisar en su chequeo. La diferencia entre glucómetro y CGM es sencilla: el glucómetro le da un número en un momento; el CGM le da la película completa del día. Para más información sobre el manejo de la diabetes, visite nuestra página en español.
Frequently asked questions
Does a CGM replace fingersticks completely?
Not entirely. Most modern systems do not require routine fingerstick calibration, but a glucometer is still recommended to confirm readings when your symptoms do not match the sensor, when glucose is changing rapidly, or when a sensor appears to be malfunctioning. Keep meter supplies on hand.
Do I need a prescription for a CGM in Puerto Rico?
It depends on the device. Prescription CGMs remain the standard for people using insulin and are typically the route required for insurance coverage. Some over-the-counter sensors are now available for adults and children who do not use insulin. A clinical evaluation is still recommended so the data is interpreted correctly.
Is a CGM covered by insurance?
Coverage varies by plan, diagnosis, and treatment regimen, and criteria change over time. Our staff can help verify your current benefits before you order supplies. Please call the office to confirm specifics for your plan.
Will a CGM lower my A1C?
It may help, but no device guarantees a specific result. A CGM provides information; the improvement comes from the treatment changes and daily decisions that information makes possible. Outcomes differ from patient to patient and depend on your overall plan.
Can I wear a CGM in the shower, the pool, or at the beach?
Most current sensors are water-resistant for showering and swimming within manufacturer-specified depth and time limits. Heat, humidity, salt water, and sunscreen do affect adhesive life, so an overpatch is a practical addition here on the north coast.
¿Puedo usar un CGM si tengo prediabetes?
Sí, es posible, pero los resultados deben interpretarse con cuidado. En personas sin diabetes, los datos del sensor no siempre corresponden con la A1C, así que le recomendamos traer el informe a su cita en lugar de sacar conclusiones por su cuenta.
Talk to a specialist before you start
A sensor is only as useful as the plan built around it. If you are considering a CGM — or already wearing one and unsure what the report means — bring it to a specialist who treats diabetes every day. EndoInnova provides endocrinology-led care for Type 1 and Type 2 diabetes, prediabetes, thyroid conditions, obesity and weight management, and metabolic disorders for patients in Hatillo, Camuy, Quebradillas, Arecibo, Manatí, Barceloneta, and across Puerto Rico.
Book an appointment online or call +1 787-956-0909 to schedule an evaluation with a diabetes endocrinologist in Puerto Rico.
More endocrinology patient resources: explore our diabetes and thyroid education Puerto Rico library on the EndoInnova blog for additional endocrinologist articles on glucose monitoring, thyroid health, and metabolic care.
Medical disclaimer: This article is intended for general education and does not constitute medical advice, diagnosis, or treatment. Individual results and recommendations vary. Do not start, stop, or change any medication, device, or monitoring plan without consulting your physician.
Educación de salud simplificada
Ya seas paciente o simplemente sientas curiosidad por tu composición corporal, nuestra evaluación InBody ofrece información más profunda sobre el músculo, la grasa y la salud metabólica, más allá de la báscula. Reserva tu cita fácilmente en línea con el soporte de un asistente virtual para una experiencia rápida y sin complicaciones.
